Delivery Order SPE2DB24D2012-SPE2DB24FBUUJ
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA). The $2,916.00 firm fixed price delivery order has a completion date of May 24, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of 4565047848 ADVAIR HFA 230-21 MCG INHALER 12GM to the Defense Logistics Agency (DLA). The $26,012.53 firm fixed price Delivery Order contract has a completion date of July 2, 2024 and was awarded on July 1, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product ADVAIR HFA 230-21 MCG INHALER 12GM. The $12,326.04 Firm Fixed Price Delivery Order was awarded on May 31, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, with a completion date of June 3, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The $1,325.24 firm fixed price delivery order contract has an ultimate completion date of April 24, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This IDC serves as...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,829,019 units of the pharmaceutical product ADVAIR HFA 230-21 MCG INHALER 12GM. The $4,276.83 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with a performance period ending on June 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,580.34 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. This contract is for the supply of 4564658894 ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, with a completion date of May 21, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $10,304.20 firm fixed-price delivery order is for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product. The contract has an ultimate completion date of March 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,248.92 firm fixed-price delivery order is for the supply of ADVAIR HFA 45-21 MCG INHALER 12GM, a pharmaceutical product. The contract has an ultimate completion date of January 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of ADVAIR HFA 45-21 MCG INHALER 12GM medical supplies. The $4,107.87 firm fixed-price delivery order has a completion date of June 12, 2024. This award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,585.14 fixed-price contract, awarded on May 15, 2024, has a completion date of May 16, 2024 and is not set aside for any special designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB24D2012Indefinite Delivery Contract
- SPE2DB24D2012-SPE2DB24FBUUJDelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The $4,903.36 firm fixed-price delivery order has an ultimate completion date of April 25, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense worldwide. The company also has a smaller IDC valued up to $750,000 with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. This contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 4/24/24 |